Cardiac and Inflammatory Biomarker Differences in Adverse Cardiac Events after Chimeric Antigen Receptor T-Cell Therapy: an Exploratory Study

Cardio-oncology（2023）

引用 1|浏览20

暂无评分

摘要

Chimeric antigen receptor T- Cell (CAR-T) immunotherapy has been a breakthrough treatment for various hematological malignancies. However, cardiotoxicities such as new-onset heart failure, arrhythmia, acute coronary syndrome and cardiovascular death occur in 10–15

查看译文

关键词

Chimeric antigen receptor T cell,Cardiotoxicity,Cardio-oncology,Cardiac biomarker,Tocilizumab,Inflammatory cytokines

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要